DGAP-News: MeVis Medical Solutions AG: Upward trend stabilized in Q2 2012
(firmenpresse) - DGAP-News: MeVis Medical Solutions AG / Key word(s): Half Year
Results/Interim Report
MeVis Medical Solutions AG: Upward trend stabilized in Q2 2012
27.08.2012 / 07:30
---------------------------------------------------------------------
MeVis' upward trend stabilized in Q2 2012
Significantly improved profitability and increased liquidity with slightly
rising sales
- Group sales grew moderately to EUR 6.9 million in the first six months
(prev. year: EUR 6.7 million).
- License and maintenance business increased, the maintenance business
share remained constant at 43 %.
- Earnings before interest and taxes (EBIT) climbed to EUR 1.3 million
(prev. year: EUR 0.2 million).
- Liquidity rose further to EUR 9.0 million (end of 2011: EUR 7.5
million).
Bremen, August 27, 2012 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4],
a leading provider of medical imaging software, today announced its results
for the first half of 2012.
Sales in the first half of 2012 amounted to EUR 6,878 k, 3 % above the
first half of 2011 (EUR 6,688 k) with both license (+2 %) and maintenance
(+3 %) business contributing to this growth. The share of maintenance
business remained constant at 43 % of total sales in the first half of the
year.
Sales in the Digital Mammography segment went down slightly by 1 % to EUR
5,145 k compared to the strong first half of 2011 (prev. year: EUR 5,191
k). Sales in the Other Diagnostics segment developed positively, rising by
16 % to EUR 1,733 k (prev. year: EUR 1,497 k).
Sales in the second quarter of 2012 came to EUR 3,241 k, corresponding to a
9 % increase year-on-year.
In the first half of 2012, capitalization of development costs went up by 8
% to EUR 1,409 k compared to the previous year's period.
Personnel expenses dropped by a total of 9 % year-on-year in both the
second quarter and the first six months and amounted to EUR 4,422 k in the
first half of the year. At the same time, other operating expenses could be
reduced noticeably again by 19 % to EUR 1,158 k on account of the
continuing cost savings measures.
After depreciation and amortization of EUR 1,656 k (7 % down year-on-year),
earnings before interest and taxes (EBIT) increased by around EUR 1.1
million - one of the main reasons being the cost savings measures?to EUR
1,256 k (prev. year: EUR 181 k) in the first half of the year. The EBIT
margin rose steeply to 18 % as a result (prev. year: 3 %).
The net financial result of EUR 254 k (prev. year: EUR -617 k) also
improved considerably, with the results of operation of the Dutch
investment Medis and the strong US dollar contributing to this development.
Pre-tax earnings rose correspondingly by almost EUR 2 million to EUR 1,510
k in the period under review (prev. year: EUR -436 k). Taking into account
income tax expenses of EUR 844 k, a figure on par with the previous year
and which is still primarily influenced by non-cash deferred taxes, MeVis
closed the first half of the current financial year with consolidated net
profit of EUR 666 k (prev. year: -1,172 k). Earnings per share therefore
amounted to EUR 0.39 (prev. year: EUR -0.68).
Liquid funds increased again in the second quarter and amounted to EUR
9,037 k on June 30, 2012 (compared to EUR 7,749 k on March 31, 2012 and EUR
7,506 k on December 31, 2011).
'Following the positive first half of 2012, we are confirming our 2012
guidance in which we forecast Group sales to stabilize at the previous
year's level. We expect the EBIT to rise slightly as a result of our
improved cost position,' said Dr. Robert Hannemann, CFO of MeVis Medical
Solutions AG. 'We also anticipate further positive liquidity from operating
activities in 2012, whereby a purchase price payment of EUR 3.0 million as
part of the acquisition of the 49% stake in MBS KG will be due for the last
time this year, which will have a corresponding impact on liquidity.'
'We have successfully started implementing our strategic reorientation.
During our visits, we reassured our industrial customers that we will be
increasingly focusing our business activities on their needs,' added Marcus
Kirchhoff, CEO of MeVis Medical Solutions AG. 'We have also started our
internal restructuring process. We have, for instance, provided the first
resources for developing the new strategic business field, online services,
from which we expect medium-term growth.'
The financial reports of the company can be downloaded at
http://www.mevis.de/mms/Finanzberichte.html.
End of Corporate News
---------------------------------------------------------------------
27.08.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MeVis Medical Solutions AG
Universitätsallee 29
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 11
E-mail: ir(at)mevis.de
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
182849 27.08.2012
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 27.08.2012 - 07:30 Uhr
Sprache: Deutsch
News-ID 177563
Anzahl Zeichen: 7334
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 238 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: MeVis Medical Solutions AG: Upward trend stabilized in Q2 2012"
steht unter der journalistisch-redaktionellen Verantwortung von
MeVis Medical Solutions AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
